Navigation Links
PharmaForce Inc. Receives FDA Approval for First Generic of Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP
Date:7/31/2009

COLUMBUS, Ohio, July 31 /PRNewswire/ -- PharmaForce, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension, USP, a generic version of Schering Corporation's Celestone(R) Soluspan(R).

PharmaForce's product is manufactured in the USA and is marketed in a 6 mg/mL (3 mg base betamethasone/mL; 3 mg/mL betamethasone acetate), 5mL vial dosage form.

Shipment of this product has commenced and is available through wholesalers and distributors.

"PharmaForce is proud to be providing the healthcare community with this first generic equivalent of Celestone(R) Soluspan(R)," said Nicholas Uchyn, Vice President of Sales.

About PharmaForce, Inc.

PharmaForce, Inc., founded in 1999, is a privately held specialty pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. PharmaForce specializes in injectable, ophthalmic and otic products with more than 35 FDA approved medicines as well as over 30 additional products in development.

For more information about Betamethasone Sodium Phosphate and Betamethasone Acetate Injectable Suspension and PharmaForce, Inc., please visit: www.pharmaforceinc.com.

Please refer to www.pharmaforceinc.com for full prescribing information.

Celestone(R) Soluspan(R) is a registered trademark of Schering Corporation.

    Media Contact:
    Nicholas Uchyn
    Vice President of Sales
    PharmaForce, Inc.
    960 Crupper Avenue
    Columbus, Ohio 43229
    614/436-2222
    nuchyn@pharmaforceinc.com


'/>"/>
SOURCE PharmaForce, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caldwell College Receives Approval to Launch First Ph.D. for Applied Behavior Analysis-Autism Treatment in New Jersey
2. Pitt receives $13.4 million NIH grant to create virtual models for epidemics
3. Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom
4. TriReme Medical, Inc. Receives CE Marking for Glider(TM) PTCA Dilatation Catheter
5. New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA
6. GenVec Receives Grant for Malaria Vaccine Program
7. Olympus Managed Health Care Receives Third Party Administrative License in State of Florida
8. Diplomat Specialty Pharmacy Receives Regional Good Neighbor Pharmacy Of The Year Award
9. Lilly Receives Award From National Medical Association
10. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
11. Assara Laser Hair Removal Centers (New York, NY) Receives 2008 New York Award for Cosmetology & Personal Hygiene Salons by the U.S.C.A.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: